Outcomes of Treatment with Neoadjuvant Cemiplimab for Patients with Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial

Ferrarotto, R., Nagarajan, P., Maronge, J. M., Johnson, J. M., Rosenthal, D. I., Myers, J. N., & Gross, N. D. (2023). Outcomes of Treatment with Neoadjuvant Cemiplimab for Patients with Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck: Secondary Analysis of a Phase 2 Clinical Trial. In JAMA Otolaryngology - Head and Neck Surgery (Vol. 149, pp. 847–849). American Medical Association. https://doi.org/10.1001/jamaoto.2023.1729